
  
    
      
        Introduction_NNP
        AS_NNP is_VBZ an_DT inflammatory_JJ rheumatic_JJ disease_NN mainly_RB involving_VBG
        the_DT axial_NN skeleton_NN ._. Forty_CD percent_NN of_IN AS_NNP patients_NNS develop_VBP
        periphery_NN mono-_NN /_NN oligoarthritis_NNS [_NN 1_CD ]_NN ._.
        The_DT SM_NNP of_IN inflamed_JJ peripheral_JJ joints_NNS in_IN AS_NNP (_( Fig_NNP ._. 1_LS )_) in_IN
        certain_JJ cases_NNS resembles_VBZ RA_NNP with_IN intense_JJ mononuclear_NN cell_NN
        infiltration_NN forming_VBG foci_NN similar_JJ to_TO germinal_NN centers_NNS (_( GC_NNP )_)
        that_WDT contain_VBP B_NNP and_CC T_NN lymphocytes_NNS as_RB well_RB as_IN plasma_NN cells_NNS [_NN
        2_CD ,_, 3_CD ]_NN ._. Recent_JJ immunohistologic_JJ analysis_NN of_IN five_CD AS_NNP SMs_NNP
        demonstrated_VBD B_NNP cell_NN rich_JJ infiltrates_NNS in_IN two_CD cases_NNS ,_, whereas_IN
        no_DT B_NNP cells_NNS were_VBD detected_VBN in_IN the_DT three_CD others_NNS [_NN 4_CD ]_NN ._.
        The_DT VH_NNP germline_NN repertoire_NN consists_VBZ of_IN 123_CD (_( 44_CD
        functional_JJ )_) VH_NNP segments_NNS subdivided_JJ into_IN seven_CD VH_NNP families_NNS
        (_( see_VB supplementary_JJ material_NN )_) ._. Antibodies_NNP are_VBP encoded_JJ by_IN one_CD
        VH_NNP segment_NN rearranged_JJ to_TO one_CD or_CC several_JJ of_IN 25_CD heavy_JJ chain_NN
        diversity_NN segments_NNS (_( DHs_NNP )_) and_CC one_CD of_IN six_CD JHs_NNP [_NN 5_CD ]_NN ._. The_DT locus_JJ
        of_IN rearrangement_NN ,_, individual_JJ for_IN each_DT B_NNP lymphocyte_NN clone_NN ,_,
        is_VBZ the_DT CDR_NNP 3_CD [_NN 6_CD ]_NN ._. Only_RB rearrangements_NNS with_IN translatable_JJ
        nucleotide_NN triplets_NNS lead_VBP to_TO antibody_NN formation_NN ,_, others_NNS are_VBP
        nonfunctional_NN ._. There_EX is_VBZ a_DT biased_VBN use_NN of_IN particular_JJ germline_NN
        VH_NNP genes_NNS in_IN the_DT VH_NNP repertoire_NN ._. An_DT over-representation_JJ of_IN
        VH_NNP 4_CD genes_NNS in_IN the_DT autoimmune_JJ repertoire_NN has_VBZ been_VBN described_VBN [_NN
        7_CD ,_, 8_CD ]_NN ._. A_DT negative_JJ selection_NN of_IN VH_NNP 4_CD takes_VBZ place_NN in_IN the_DT
        peripheral_JJ blood_NN lymphocytes_NNS from_IN healthy_JJ individuals_NNS as_IN a_DT
        means_NN of_IN avoiding_VBG autoimmunity_NN [_NN 9_CD ]_NN ._.
        An_DT antigen-driven_JJ immune_JJ response_NN ,_, characterized_VBN by_IN a_DT
        ratio_NN of_IN mutations_NNS leading_VBG to_TO amino_JJ acid_NN replacement_NN to_TO
        silent_JJ mutations_NNS (_( R_NN :_: S_NNP ratio_NN )_) >_NN 3_CD [_NN 10_CD ]_NN within_IN the_DT
        complementarity_NN determining_VBG region_NN (_( CDR_NNP )_) ,_, takes_VBZ place_NN
        within_IN the_DT GC_NNP of_IN lymphatic_JJ organs_NNS ._. Similar_JJ clonal_NN
        development_NN of_IN antibody_NN VH_NNP genes_NNS has_VBZ been_VBN demonstrated_VBN in_IN
        the_DT SM_NNP in_IN RA_NNP patients_NNS [_NN 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ]_NN and_CC in_IN reactive_JJ
        arthritis_NN (_( ReA_NNP )_) patients_NNS [_NN 16_CD ]_NN ._. The_DT B_NNP cell_NN subset_NN in_IN AS_NNP
        joints_NNS has_VBZ not_RB yet_RB been_VBN characterized_VBN ._. We_PRP analyzed_VBD the_DT
        repertoire_NN and_CC distribution_NN of_IN rearranged_JJ VH_NNP genes_NNS to_TO
        elucidate_NN B_NNP lymphocyte_NN involvement_NN in_IN AS_NNP ,_, and_CC to_TO
        investigate_VB similarities_NNS to_TO and_CC differences_NNS from_IN RA_NNP ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Tissue_NNP preparation_NN and_CC staining_VBG
          A_DT SM_NNP of_IN the_DT right_JJ hip_NN was_VBD obtained_VBN from_IN a_DT 57_CD -_: year-old_JJ
          man_NN ,_, who_WP had_VBD suffered_VBN from_IN AS_NNP for_IN 30_CD years_NNS ,_, requiring_VBG
          total_JJ endoprothetic_JJ joint_JJ replacement_NN ._. Frozen_NNP sections_NNS (_( 8_CD
          μm_NN )_) of_IN the_DT immediately_RB snap-frozen_JJ tissue_NN sample_NN were_VBD
          screened_VBD for_IN B_NNP and_CC T_NN cells_NNS by_IN double_JJ immunohistological_JJ
          staining_VBG with_IN anti-_NN CD_NNP 20_CD and_CC anti-_NN CD_NNP 3_CD monoclonal_NN
          antibodies_NNS using_VBG the_DT alkaline_NN phosphatase-anti-alkaline_JJ
          phosphatase_NN and_CC streptavidin_NN biotin_NN horseradish_NN
          peroxidase_NN technique_NN [_NN 17_CD ,_, 18_CD ]_NN ._. The_DT stained_JJ B_NNP lymphocytes_NNS
          from_IN serial_NN sections_NNS taken_VBN at_IN 50_CD μm_NN intervals_NNS were_VBD
          isolated_VBN by_IN microdissection_NN ,_, and_CC DNA_NNP preparation_NN followed_VBN
          (_( see_VB supplementary_JJ material_NN )_) ._.
        
        
          VH_NNP PCR_NNP
          DNA_NNP was_VBD subjected_VBN to_TO a_DT semi-nested_JJ PCR_NNP for_IN VH_NNP genes_NNS
          (_( see_VB supplementary_JJ material_NN )_) ._. Thirty-five_CD cycles_NNS of_IN PCR_NNP ,_,
          using_VBG a_DT mix_NN of_IN six_CD oligonucleotides_NNS specific_JJ for_IN the_DT
          different_JJ VH_NNP families_NNS as_IN primers_NNS at_IN the_DT 5_CD '_POS end_NN and_CC a_DT mix_NN
          of_IN oligonucleotides_NNS corresponding_JJ to_TO the_DT known_VBN JH_NNP
          overlapping_VBG to_TO a_DT part_NN of_IN the_DT intron_NN sequence_NN as_IN primers_NNS
          at_IN the_DT 3_CD '_POS end_NN ,_, were_VBD followed_VBN by_IN 35_CD cycles_NNS with_IN 1_CD μl_NN of_IN
          the_DT first_JJ PCR_NNP products_NNS and_CC individual_JJ VH_NNP and_CC JH_NNP primers_NNS
          (_( at_IN a_DT more_JJR 5_CD '_POS position_NN )_) (_( Table_NNP 1_LS )_) ._. A_DT similar_JJ PCR_NNP without_IN
          DNA_NNP was_VBD run_VBN as_IN a_DT negative_JJ control_NN ._.
        
        
          Template_NNP generation_NN and_CC sequence_NN analysis_NN
          PCR_NNP products_NNS of_IN the_DT expected_VBN 350_CD base_NN pair_NN (_( bp_NN )_) length_NN
          were_VBD detected_VBN by_IN standard_JJ agarose_NN gel_NN electrophoresis_NNS and_CC
          purified_JJ ._. The_DT purified_JJ DNA_NNP template_NN was_VBD bacterially_RB
          subcloned_JJ followed_VBN by_IN plasmid_NN isolation_NN and_CC sequencing_VBG ._.
          Sequences_NNP were_VBD analyzed_VBN by_IN homology_NN comparison_NN with_IN the_DT
          EMBL_NNP and_CC GenBank_NNP gene_NN databases_NNS (_( see_VB supplementary_JJ
          material_NN )_) ._.
        
      
      
        Results_NNS
        
          The_DT VH_NNP gene_NN usage_NN
          Except_IN for_IN the_DT negative_JJ control_NN ,_, all_DT VH_NNP PCRs_NNP led_VBD to_TO a_DT
          product_NN of_IN the_DT expected_VBN length_NN (_( 350_CD bp_NN )_) ._. All_DT sequences_NNS
          reported_VBD in_IN the_DT present_JJ paper_NN are_VBP accessible_JJ on_IN the_DT EMBL_NNP
          database_NN ._.
          Seventy_CD individually_RB rearranged_JJ VH_NNP genes_NNS were_VBD
          characterized_VBN by_IN sequence_NN analysis_NN (_( Table_NNP 2_LS )_) :_: 14_CD (_( 20_CD %_NN )_)
          belonged_VBD to_TO the_DT VH_NNP 1_CD family_NN ,_, 3_CD (_( 4_CD %_NN )_) to_TO VH_NNP 2_CD ,_, 38_CD (_( 54_CD %_NN )_) to_TO
          VH_NNP 3_CD ,_, 7_CD (_( 10_CD %_NN )_) to_TO VH_NNP 4_CD ,_, and_CC 8_CD (_( 11_CD %_NN )_) belonged_VBD to_TO the_DT VH_NNP 5_CD
          family_NN ._. No_DT sequences_NNS corresponded_VBD to_TO VH_NNP 6_CD (_( Fig_NNP ._. 2_LS )_) ._.
          Twelve_CD genes_NNS in_IN all_DT were_VBD nonfunctionally_RB rearranged_JJ ,_,
          with_IN the_DT highest_JJS proportion_NN in_IN VH_NNP 3_CD (_( 18_CD %_NN )_) ,_, about_IN 14_CD %_NN in_IN
          VH_NNP 1_CD ,_, VH_NNP 4_CD and_CC VH_NNP 5_CD ,_, and_CC none_NN in_IN VH_NNP 2_CD ._.
        
        
          VH_NNP 1_CD genes_NNS
          Fourteen_CD individual_JJ rearrangements_NNS represented_VBD VH_NNP 1_CD
          genes_NNS ._. The_DT most_RBS often_RB represented_VBD VH_NNP 1_CD gene_NN was_VBD DP_NNP 75_CD (_( four_CD
          products_NNS )_) followed_VBN by_IN DP_NNP 10_CD ,_, DP_NNP 14_CD ,_, DP_NNP 21_CD and_CC DP_NNP 25_CD (_( two_CD
          products_NNS each_DT )_) ._. Out_IN of_IN 14_CD distinct_JJ VH_NNP 1_CD -_: DH-JH_NNP sequences_NNS ,_, 2_CD
          were_VBD nonfunctional_NN (_( 14_CD %_NN )_) ._. CDR_NNP 3_CD lengths_NNS varied_VBD between_IN 18_CD
          and_CC 39_CD bp_NN (_( mean_VB ,_, 28_CD ._. 5_LS bp_NN )_) ._.
          Four_CD of_IN the_DT VH_NNP 1_CD products_NNS (_( F_NN 5_CD -_: 2_CD c_SYM 4_CD ,_, F_NN 5_CD -_: 3_CD a_DT 4_CD ,_, F_NN 5_CD -_: 3_CD b_SYM 4_CD and_CC
          5_CD c-_NN 4_CD m_NN 6_CD )_) deriving_VBG from_IN different_JJ slides_NNS had_VBD an_DT identically_RB
          rearranged_JJ CDR_NNP 3_CD and_CC consecutively_RB represent_VB members_NNS of_IN an_DT
          expanding_VBG B_NNP lymphocyte_NN clone_NN (_( Fig_NNP ._. 3_LS a_DT )_) ._. With_IN 99_CD %_NN homology_NN
          to_TO DP_NNP 21_CD ,_, they_PRP shared_VBD three_CD mutations_NNS within_IN the_DT framework_NN
          region_NN (_( FR_NNP )_) ._.
          Five_CD productively_RB rearranged_JJ genes_NNS were_VBD highly_RB mutated_VBN
          with_IN a_DT range_NN of_IN 12_CD (_( F_NN 5_CD -_: 3_CD a_DT 3_LS )_) to_TO 29_CD mutations_NNS to_TO their_PRP$
          respective_JJ germline_NN (_( gl_NN )_) gene_NN ._. The_DT R_NN :_: S_NNP ratio_NN for_IN the_DT CDR_NNP
          was_VBD >_NN 3_CD and_CC lower_JJR for_IN the_DT FR_NNP ,_, indicating_VBG antigen-driven_JJ
          mutation_NN [_NN 10_CD ]_NN ._.
        
        
          VH_NNP 2_CD genes_NNS
          Three_CD different_JJ VH_NNP 2_CD rearrangements_NNS were_VBD determined_VBN ._.
          All_DT were_VBD potentially_RB functional_JJ and_CC >_NN 95_CD %_NN homologous_RB
          to_TO the_DT respective_JJ gl_NN gene_NN ._. The_DT number_NN of_IN mutations_NNS ranged_VBD
          from_IN 2_CD (_( 5_CD c-_NN VH_NNP 22_CD s_VBZ )_) to_TO 10_CD (_( 5_CD c-_NN VH_NNP 26_CD s_VBZ )_) ._. R_NN :_: S_NNP ratios_NNS were_VBD quite_RB
          low_JJ ,_, with_IN a_DT maximum_NN of_IN 2_CD ._. 0_CD in_IN the_DT CDR_NNP (_( 5_CD c-_NN VH_NNP 26_CD s_VBZ )_) ._. CDR_NNP 3_CD
          lengths_NNS varied_VBD between_IN 15_CD and_CC 45_CD bp_NN (_( mean_VB ,_, 32_CD bp_NN )_) ._.
        
        
          VH_NNP 3_CD genes_NNS
          Thirty-eight_NNP different_JJ VH_NNP 3_CD rearrangements_NNS were_VBD
          characterized_VBN :_: eight_CD were_VBD most_RBS homologous_RB to_TO DP_NNP 47_CD /_NN V_NNP 3_CD -_: 23_CD
          (_( 21_CD %_NN )_) ,_, five_CD to_TO DP_NNP 50_CD (_( 13_CD %_NN )_) ,_, four_CD each_DT to_TO DP_NNP 54_CD and_CC DP_NNP 31_CD
          (_( 11_CD %_NN )_) ,_, respectively_RB ,_, and_CC three_CD each_DT to_TO DP_NNP 49_CD ,_, DP_NNP 35_CD ,_, DP_NNP 51_CD
          and_CC DP_NNP 77_CD (_( 8_CD %_NN )_) ,_, respectively_RB ._. Seven_CD (_( 18_CD ._. 4_LS %_NN )_) VH_NNP 3_CD genes_NNS were_VBD
          nonfunctionally_RB rearranged_JJ ._. CDR_NNP 3_CD lengths_NNS varied_VBD from_IN 6_CD to_TO
          35_CD bp_NN (_( mean_VB ,_, 27_CD ._. 2_LS bp_NN )_) ._.
          One_CD case_NN of_IN clonal_NN expansion_NN within_IN the_DT VH_NNP 3_CD genes_NNS was_VBD
          observed_VBN ,_, represented_VBN by_IN the_DT VH_NNP 3_CD -_: JH_NNP 4_CD rearrangements_NNS
          3_CD a-_NN 19_CD m_NN 6_CD and_CC 2_CD c-_NN 19_CD m_NN 8_CD (_( Fig_NNP ._. 3_LS b_SYM )_) ._. These_DT genes_NNS ,_, with_IN 95_CD ._. 5_LS %_NN
          homology_NN to_TO DP_NNP 54_CD ,_, shared_VBD four_CD replacement_NN mutations_NNS ,_, and_CC
          six_CD mutations_NNS each_DT were_VBD localized_JJ at_IN different_JJ
          positions_NNS ._.
          Twenty-three_NNP of_IN the_DT VH_NNP 3_CD sequences_NNS were_VBD highly_RB mutated_VBN
          (_( 10_CD -_: 27_CD mutations_NNS )_) ._. Except_IN for_IN one_CD case_NN ,_, most_JJS of_IN the_DT
          mutations_NNS were_VBD localized_JJ in_IN the_DT CDR_NNP with_IN R_NN :_: S_NNP ratio_NN >_NN 3_CD ._.
          Three_CD of_IN seven_CD nonfunctionally_RB rearranged_JJ genes_NNS also_RB
          revealed_VBD a_DT pattern_NN of_IN antigen-induced_JJ mutation_NN ._.
        
        
          VH_NNP 4_CD genes_NNS
          Seven_CD different_JJ VH_NNP 4_CD rearrangements_NNS could_MD be_VB
          characterized_VBN ;_: six_CD were_VBD potentially_RB functional_JJ ._. CDR_NNP 3_CD
          lengths_NNS ranged_VBD from_IN 12_CD to_TO 45_CD bp_NN (_( mean_VB ,_, 28_CD bp_NN )_) ._.
          The_DT gl_NN genes_NNS HUMIGHCAK_NNP ,_, HUMIGHCAG_NNP and_CC DP_NNP 63_CD were_VBD
          represented_VBN twice_RB each_DT ,_, and_CC DP_NNP 71_CD once_RB ._. No_DT homology_NN to_TO
          DP_NNP 64_CD /_NN VH_NNP 4_CD -_: 34_CD /_NN VH_NNP 4_CD ._. 21_CD was_VBD seen_VBN ._. Five_CD of_IN the_DT sequences_NNS had_VBD
          few_JJ mutations_NNS (_( one_CD to_TO eight_CD )_) with_IN a_DT R_NN :_: S_NNP ratio_NN higher_JJR in_IN
          the_DT FR_NNP than_IN in_IN the_DT CDR_NNP ._. Two_CD VH_NNP 4_CD rearrangements_NNS had_VBD a_DT R_NN :_: S_NNP
          ratio_NN >_NN 3_CD in_IN the_DT CDR_NNP (_( 5_CD c-_NN VH_NNP 44_CD a_DT and_NN 3_CD b-_NN VH_NNP 45_CD a_DT )_) ._.
        
        
          VH_NNP 5_CD genes_NNS
          Eight_CD distinct_JJ VH_NNP 5_CD rearrangements_NNS could_MD be_VB determined_VBN ;_:
          seven_CD were_VBD potentially_RB functional_JJ ._. CDR_NNP 3_CD lengths_NNS ranged_VBD
          from_IN 12_CD to_TO 66_CD bp_NN (_( mean_VB ,_, 39_CD ._. 8_CD bp_NN )_) ._.
          The_DT 3_CD a-_NN VH_NNP 54_CD s_VBZ gene_NN was_VBD unmutated_JJ ._. There_EX were_VBD 7_CD -_: 35_CD
          mutations_NNS in_IN all_DT other_JJ sequences_NNS ._. For_IN five_CD sequences_NNS
          (_( four_CD were_VBD potentially_RB functional_JJ )_) ,_, the_DT mutational_NN
          pattern_NN revealed_VBD antigen_NN induction_NN ._.
        
      
      
        Discussion_NNP
        
          VH_NNP PCR_NNP
          Analysis_NNP of_IN rearranged_JJ VH_NNP genes_NNS from_IN B_NNP lymphocyte_NN DNA_NNP
          by_IN PCR_NNP and_CC sequencing_VBG enabled_VBN characterization_NN of_IN the_DT
          clonal_NN expansion_NN and_CC mutational_NN patterns_NNS without_IN bias_NN due_JJ
          to_TO cell_NN isolation_NN procedures_NNS ._. By_IN semi-nested_JJ PCR_NNP ,_,
          otherwise_RB used_VBN for_IN single-cell_JJ analysis_NN [_NN 19_CD ]_NN ,_, one_CD sole_JJ
          VH-DH-JH_NNP rearrangement_NN might_MD be_VB identified_VBN ._. Besides_IN the_DT
          extreme_JJ sensitivity_NN ,_, there_EX is_VBZ a_DT high_JJ risk_NN of_IN artificial_JJ
          amplifications_NNS because_IN of_IN contamination_NN ._. A_DT negative_JJ
          control_NN without_IN DNA_NNP was_VBD run_VBN with_IN each_DT PCR_NNP as_IN a_DT
          precaution_NN :_: no_DT contamination_NN was_VBD detected_VBN ._. We_PRP cannot_NN
          exclude_VBP the_DT fact_NN that_IN highly_RB mutated_VBN genes_NNS are_VBP amplified_VBN
          less_RBR efficiently_RB [_NN 20_CD ]_NN ._. However_RB ,_, since_IN the_DT respective_JJ
          data_NN concerning_VBG RA_NNP and_CC ReA_NNP have_VBP been_VBN established_VBN by_IN
          similar_JJ PCR_NNP approaches_NNS [_NN 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ]_NN ,_, a_DT
          comparison_NN is_VBZ possible_JJ ._.
        
        
          The_DT VH_NNP gene_NN usage_NN
          Within_IN 70_CD VH-DH-JH_NNP rearrangements_NNS characterized_VBN in_IN
          this_DT study_NN ,_, all_DT known_VBN human_JJ VH_NNP families_NNS except_IN VH_NNP 6_CD were_VBD
          represented_VBN ._. The_DT descending_VBG order_NN of_IN representation_NN was_VBD :_:
          VH_NNP 3_CD (_( 54_CD %_NN )_) ,_, VH_NNP 1_CD (_( 20_CD %_NN )_) ,_, VH_NNP 5_CD (_( 11_CD %_NN )_) ,_, VH_NNP 4_CD (_( 10_CD %_NN )_) ,_, VH_NNP 2_CD (_( 4_CD %_NN )_) ._.
          Compared_VBN with_IN the_DT germline_NN representation_NN [_NN 5_CD ]_NN ,_, an_DT
          over-representation_JJ of_IN VH_NNP 5_CD and_CC an_DT under-representation_JJ of_IN
          VH_NNP 4_CD genes_NNS were_VBD remarkable_JJ ._. The_DT representation_NN of_IN VH_NNP 1_CD ,_, VH_NNP 2_CD
          and_CC VH_NNP 3_CD genes_NNS corresponded_VBD to_TO their_PRP$ respective_JJ germline_NN
          representation_NN ._. Our_PRP$ previous_JJ studies_NNS of_IN the_DT VH_NNP gene_NN
          repertoire_NN in_IN RA_NNP SM_NNP [_NN 13_CD ]_NN and_CC studies_NNS using_VBG a_DT hybridoma_NN
          approach_NN [_NN 8_CD ]_NN revealed_VBD an_DT over-representation_JJ of_IN VH_NNP 4_CD and_CC
          a_DT biased_VBN set_NN of_IN represented_VBD VH_NNP 4_CD genes_NNS ._. A_DT positive_JJ
          selection_NN of_IN VH_NNP 4_CD genes_NNS ,_, particularly_RB within_IN the_DT plasma_NN
          cell_NN subset_NN ,_, was_VBD recently_RB demonstrated_VBN in_IN RA_NNP and_CC ReA_NNP [_NN
          16_CD ]_NN ._. The_DT DP_NNP 64_CD /_NN VH_NNP 4_CD -_: 34_CD /_NN VH_NNP 4_CD ._. 21_CD gene_NN encoding_VBG anti-_NN I_PRP and_CC
          anti-i_JJ specificity_NN of_IN cold_JJ agglutinins_NNS [_NN 21_CD ,_, 22_CD ]_NN ,_, as_RB well_RB
          as_IN anti-_NN DNA_NNP antibodies_NNS in_IN lupus_JJ erythmatosus_JJ [_NN 23_CD ]_NN ,_, was_VBD
          not_RB detected_VBN within_IN the_DT VH_NNP 4_CD genes_NNS from_IN AS_NNP SM_NNP ._.
          Another_DT autoimmunity-prone_JJ gene_NN ,_, the_DT DP_NNP 47_CD /_NN V_NNP 3_CD -_: 23_CD gene_NN ,_,
          was_VBD also_RB predominant_NN in_IN AS_NNP ._. All_DT of_IN eight_CD V_NNP 3_CD -_: 23_CD -_: derived_VBN
          genes_NNS were_VBD potentially_RB functional_JJ rearrangements_NNS with_IN
          >_NN 3_CD %_NN mutations_NNS to_TO the_DT gl_NN sequence_NN ,_, and_CC four_CD reveal_VB a_DT
          R_NN :_: S_NNP ratio_NN >_NN 3_CD within_IN the_DT CDR_NNP that_WDT indicates_VBZ a_DT selection_NN
          by_IN antigen_NN ._. V_NNP 3_CD -_: 23_CD was_VBD also_RB predominant_NN in_IN RA_NNP SM_NNP [_NN 24_CD ]_NN ._. A_DT
          comparison_NN of_IN the_DT peripheral_JJ repertoire_NN revealed_VBD that_IN
          V_NNP 3_CD -_: 23_CD was_VBD more_RBR often_RB somatically_RB mutated_VBN in_IN RA_NNP than_IN in_IN
          healthy_JJ controls_NNS [_NN 9_CD ,_, 25_CD ,_, 26_CD ]_NN ._.
          Except_IN for_IN VH_NNP 4_CD ,_, VH_NNP 5_CD and_CC VH_NNP 6_CD ,_, the_DT representation_NN of_IN VH_NNP
          genes_NNS was_VBD similar_JJ to_TO results_NNS from_IN the_DT peripheral_JJ VH_NNP
          repertoire_NN from_IN healthy_JJ donors_NNS [_NN 27_CD ,_, 9_CD ]_NN as_RB well_RB as_IN from_IN a_DT
          RA_NNP patient_NN [_NN 28_CD ]_NN ._.
        
        
          Clonal_NNP expansion_NN
          Only_RB two_CD cases_NNS of_IN clonal_NN expansion_NN characterized_VBN by_IN
          identically_RB rearranged_JJ segments_NNS were_VBD detected_VBN on_IN
          different_JJ slides_NNS ._. An_DT accumulation_NN of_IN further_JJ point_NN
          mutations_NNS in_IN the_DT course_NN of_IN intraclonal_NN diversification_NN
          was_VBD seen_VBN in_IN two_CD offspring_NN of_IN a_DT VH_NNP 3_CD clone_NN (_( both_DT share_NN four_CD
          mutations_NNS and_CC differ_VB in_IN six_CD point_NN mutations_NNS )_) ._. Studies_NNS on_IN
          plasma_NN cells_NNS in_IN ReA_NNP and_CC RA_NNP SMs_NNP [_NN 16_CD ]_NN reveal_VB clonal_NN
          expansion_NN ._. In_IN RA_NNP SMs_NNP ,_, clonal_NN B_NNP lymphocyte_NN expansion_NN in_IN
          different_JJ areas_NNS of_IN the_DT tissue_NN samples_NNS [_NN 11_CD ,_, 15_CD ]_NN and_CC
          recirculation_NN within_IN different_JJ joints_NNS and_CC blood_NN were_VBD
          reported_VBN [_NN 14_CD ]_NN ._.
        
        
          The_DT CDR_NNP 3_CD
          The_DT CDR_NNP 3_CD lengths_NNS of_IN genes_NNS from_IN the_DT AS_NNP samples_NNS were_VBD
          short_JJ ,_, with_IN a_DT median_NN of_IN 27_CD ._. 2_LS nucleotides_NNS ._. A_DT high_JJ
          variability_NN ,_, particularly_RB in_IN the_DT productively_RB rearranged_JJ
          subset_NN and_CC in_IN the_DT VH_NNP 5_CD family_NN ,_, was_VBD noted_VBN ._. A_DT similarly_RB high_JJ
          variability_NN was_VBD shown_VBN for_IN polyreactive_JJ antibodies_NNS and_CC
          rheumatic_JJ factors_NNS in_IN RA_NNP [_NN 29_CD ]_NN ._. Our_PRP$ data_NNS from_IN RA_NNP SM_NNP
          revealed_VBD almost_RB homogeneous_JJ CDR_NNP 3_CD lengths_NNS of_IN intermediate_JJ
          size_NN [_NN 13_CD ]_NN ._. CDR_NNP 3_CD were_VBD much_JJ longer_RBR in_IN the_DT healthy_JJ
          peripheral_JJ repertoire_NN ,_, particularly_RB within_IN nonfunctional_NN
          rearrangements_NNS (_( mean_VB ,_, 54_CD nucleotides_NNS )_) [_NN 9_CD ]_NN ._.
        
        
          Mutational_NNP pattern_NN
          Only_RB nine_CD rearrangements_NNS were_VBD not_RB mutated_VBN ._. R_NN :_: S_NNP ratios_NNS
          >_NN 3_CD within_IN the_DT CDR_NNP were_VBD observed_VBN in_IN 30_CD genes_NNS (_( two_CD were_VBD
          nonfunctional_NN )_) ._. Members_NNS of_IN the_DT VH_NNP 1_CD ,_, VH_NNP 3_CD ,_, VH_NNP 4_CD and_CC VH_NNP 5_CD
          families_NNS carried_VBD more_RBR somatic_JJ mutations_NNS than_IN the_DT VH_NNP 2_CD
          genes_NNS ._.
          Mutational_NNP pattern_NN and_CC frequency_NN determine_VB about_IN one_CD
          half_NN of_IN the_DT characterized_VBN genes_NNS as_IN memory_NN B_NNP cells_NNS that_WDT
          probably_RB stay_VB in_IN contact_NN with_IN persistent_JJ antigens_NNS in_IN the_DT
          micro-environment_JJ of_IN the_DT synovial_NN foci_NN [_NN 30_CD ]_NN ._. A_DT similar_JJ
          accumulation_NN of_IN memory_NN cells_NNS in_IN RA_NNP SM_NNP has_VBZ been_VBN reported_VBN [_NN
          12_CD ,_, 31_CD ]_NN ._.
          Besides_IN the_DT highly_RB mutated_VBN genes_NNS already_RB described_VBD ,_,
          one_CD half_NN of_IN the_DT characterized_VBN genes_NNS showed_VBD no_DT evidence_NN of_IN
          antigen-induced_JJ mutations_NNS with_IN low_JJ R_NN :_: S_NNP ratios_NNS within_IN the_DT
          CDR_NNP ._. There_EX was_VBD a_DT bias_NN to_TO silent_JJ mutations_NNS in_IN four_CD highly_RB
          mutated_VBN genes_NNS (_( 2_CD c-_NN 3_CD m_NN 4_CD b_SYM ,_, 2_CD c-_NN 21_CD m_NN 3_CD ,_, 3_CD a-_NN 19_CD m_NN 8_CD and_CC 2_CD c-_NN 17_CD m_NN 9_CD )_) ._.
          This_DT pattern_NN of_IN mutations_NNS has_VBZ been_VBN described_VBN for_IN cold_JJ
          agglutinins_NNS [_NN 32_CD ]_NN ,_, as_RB well_RB as_IN for_IN rheumatic_JJ factors_NNS ,_, as_IN a_DT
          mechanism_NN of_IN selection_NN against_IN amino_JJ acid_NN replacement_NN to_TO
          prevent_VB the_DT generation_NN of_IN high-affinity_JJ autoantibodies_NNS [_NN
          33_CD ]_NN ._.
        
        
          Nonfunctional_NNP rearrangements_NNS
          Except_IN for_IN VH_NNP 2_CD (_( none_NN )_) and_CC VH_NNP 3_CD (_( 18_CD %_NN )_) ,_, nonfunctional_NN
          rearrangements_NNS had_VBD an_DT equal_JJ proportion_NN of_IN 13_CD -_: 14_CD %_NN in_IN each_DT
          family_NN within_IN the_DT genes_NNS characterized_VBN in_IN the_DT present_JJ
          paper_NN ._. Except_IN for_IN a_DT bias_NN to_TO VH_NNP 4_CD ,_, a_DT similar_JJ overall_JJ
          proportion_NN of_IN nonfunctional_NN rearrangements_NNS was_VBD seen_VBN in_IN
          the_DT peripheral_JJ blood_NN of_IN healthy_JJ donors_NNS using_VBG single-cell_JJ
          PCR_NNP of_IN genomic_JJ DNA_NNP [_NN 9_CD ]_NN ._. In_IN contrast_NN ,_, no_DT bias_NN to_TO elevated_VBD
          CDR_NNP 3_CD lengths_NNS was_VBD seen_VBN ._.
        
      
      
        Conclusion_NNP
        An_DT active_JJ immune_JJ reaction_NN with_IN GC_NNP formation_NN occurs_VBZ in_IN
        the_DT inflamed_JJ SM_NNP in_IN AS_NNP ._. B_NN cell_NN affinity_NN maturation_NN with_IN
        generation_NN of_IN somatically_RB mutated_VBN antibody-coding_JJ genes_NNS
        characteristic_JJ for_IN memory_NN cells_NNS occurs_VBZ in_IN these_DT GC_NNP
        formations_NNS ,_, indicating_VBG an_DT antigen-driven_JJ response_NN ._.
        Comparable_JJ with_IN RA_NNP and_CC ReA_NNP ,_, there_EX is_VBZ a_DT biased_VBN repertoire_NN of_IN
        selected_VBN VH_NNP genes_NNS ,_, whereas_IN the_DT panel_NN of_IN represented_VBD genes_NNS
        is_VBZ different_JJ and_CC clonal_NN expansion_NN was_VBD observed_VBN less_RBR
        frequently_RB ._.
      
      
        Supplementary_NNP material_NN
        
          Introduction_NNP
          By_IN sequence_NN homology_NN of_IN at_IN least_JJS 80_CD %_NN ,_, the_DT VH_NNP gene_NN
          segments_NNS are_VBP classified_VBN into_IN seven_CD families_NNS ._. The_DT VH_NNP 1_CD
          family_NN has_VBZ 14_CD members_NNS (_( 9_CD genes_NNS with_IN open_JJ reading_NN frames_NNS )_) ,_,
          VH_NNP 2_CD has_VBZ 4_CD (_( 3_CD genes_NNS with_IN open_JJ reading_NN frames_NNS )_) ,_, VH_NNP 3_CD has_VBZ 65_CD
          (_( 22_CD genes_NNS with_IN open_JJ reading_NN frames_NNS )_) ,_, VH_NNP 4_CD has_VBZ 32_CD (_( 7_CD genes_NNS
          with_IN open_JJ reading_NN frames_NNS )_) ,_, VH_NNP 5_CD has_VBZ 2_CD ,_, VH_NNP 6_CD has_VBZ 1_CD ,_, and_CC VH_NNP 7_CD
          has_VBZ 5_CD members_NNS (_( 1_CD gene_NN with_IN an_DT open_JJ reading_NN frame_NN )_) ,_,
          respectively_RB [_NN 5_CD ]_NN ._.
        
        
          Materials_NNS and_CC methods_NNS
          
            DNA_NN preparation_NN
            After_IN the_DT addition_NN of_IN 40_CD μl_NN H_NNP 
            2_CD O_NNP ,_, 0_CD ._. 1_CD volume_NN of_IN 10_CD ×_NN PCR_NNP buffer_NN
            (_( mentioned_VBN later_RB )_) ,_, 1_CD %_NN Triton_NNP X-_NNP 100_CD and_CC 0_CD ._. 5_CD μl_NN
            Pro-teinase_NNP K_NNP (_( 100_CD μg_NN /_NN ml_NN ;_: Merck_NNP ,_, Darmstadt_NNP ,_, Germany_NNP )_)
            was_VBD added_VBN and_CC mixed_JJ ._. The_DT volume_NN was_VBD adapted_VBN to_TO 80_CD μl_NN by_IN
            addition_NN of_IN H_NNP 
            2_CD O_NNP ._. The_DT sample_NN was_VBD incubated_JJ over_IN
            45_CD min_NN at_IN 55_CD °_NN C_NNP ._. After_IN inactivation_NN of_IN proteinase_NN
            (_( 95_CD °_NN C_NNP )_) ,_, 25_CD μl_NN of_IN the_DT solution_NN was_VBD subjected_VBN to_TO the_DT
            first_JJ PCR_NNP ._.
          
          
            Seminested_NNP VH_NNP PCR_NNP
            First_LS PCR_NNP ._. An_DT oligonucleotide_NN mix_NN of_IN VH_NNP 1_CD ,_, VH_NNP 2_CD ,_, VH_NNP 3_CD ,_,
            VH_NNP 4_CD ,_, VH_NNP 5_CD ,_, VH_NNP 6_CD and_CC an_DT oligonucleotide_NN mix_NN of_IN JH-Intron_NNP
            1_CD ,_, 2_CD -_: 4_CD ,_, 5_CD and_CC JH-Intron_NNP 3_CD ,_, 6_CD as_IN primers_NNS (_( final_JJ
            concentration_NN ,_, 0_CD ._. 125_CD μM_NN each_DT )_) ,_, 200_CD μM_NN dNTP_NN ,_, 2_CD mM_NN MgCl_NNP 2_CD ,_,
            1_CD U_NNP Goldstar_NNP Taq-polymerase_NNP (_( Eurogentec_NNP ,_, Seraing_NNP ,_,
            Belgium_NNP )_) ,_, and_CC the_DT manufacturer_NN 's_POS reaction_NN buffer_NN ._. First_LS
            cycle_NN :_: 5_CD min_NN denaturation_NN at_IN 95_CD °_NN C_NNP ,_, 3_CD min_NN annealing_VBG at_IN
            58_CD °_NN C_NNP and_CC 90_CD second_JJ extension_NN at_IN 72_CD °_NN C_NNP ;_: cycles_NNS 2_CD -_: 35_CD ,_, 80_CD
            second_JJ denaturation_NN ,_, 30_CD second_JJ annealing_VBG ,_, and_CC 90_CD second_JJ
            extension_NN ,_, with_IN a_DT final_JJ extension_NN of_IN 5_CD min_NN ._.
            Second_NNP PCR_NNP ._. One_CD microliter_NN of_IN the_DT product_NN of_IN the_DT
            first_JJ PCR_NNP with_IN individual_JJ oligonucleotide_NN primers_NNS
            VH_NNP 1_CD -_: VH_NNP 6_CD and_CC JH_NNP 1_CD -_: JH_NNP 6_CD ,_, under_IN the_DT same_JJ conditions_NNS as_IN the_DT
            first_JJ PCR_NNP except_IN for_IN annealing_VBG for_IN VH_NNP 1_CD ,_, VH_NNP 2_CD ,_, VH_NNP 5_CD ,_, VH_NNP 6_CD
            at_IN 58_CD °_NN C_NNP ,_, and_CC for_IN VH_NNP 3_CD and_CC VH_NNP 4_CD at_IN 63_CD °_NN C_NNP ._.
            DNA_NN purification_NN and_CC plasmid_NN ligation_NN were_VBD performed_VBN
            with_IN commercial_JJ kits_NNS following_VBG the_DT manufacturer_NN 's_POS
            instructions_NNS :_: DNA_NNP purification_NN from_IN the_DT agarose-gel_JJ
            with_IN the_DT QUIAquick_NNP kit_NN (_( Quiagen_NNP ,_, Hilden_NNP ,_, Germany_NNP )_) ,_, and_CC
            bacterial_JJ cloning_VBG with_IN the_DT TA-cloning_NNP kit_NN (_( Invitrogen_NNP ,_,
            Leek_NNP ,_, The_DT Netherlands_NNP )_) ._.
            For_IN DNA_NNP sequence_NN homology_NN search_NN and_CC sequence_NN
            comparison_NN ,_, DNASIS_NNP software_NN (_( Hitachi_NNP Europe_NNP ,_, Olivet_NNP ,_,
            France_NNP )_) ,_, and_CC EMBL_NNP Nucleotide_NNP Sequence_NNP Submissions_NNP
            (_( European_NNP Bioinformatics_NNP Institute_NNP ,_, Wellcome_NNP Trust_NNP
            Genome_NNP Campus_NNP ,_, Cambridge_NNP ,_, UK_NNP )_) were_VBD used_VBN ._. The_DT GenBank_NNP
            (_( National_NNP Institutes_NNPS of_IN Health_NNP ,_, Bethesda_NNP ,_, MD_NNP ,_, USA_NNP )_) was_VBD
            also_RB used_VBN ._.
          
        
      
      
        Abbreviations_NNP
        AS_NNP =_SYM ankylosing_VBG spondylitis_NNS ;_: CDR_NNP =_SYM complementarity_NN
        determining_VBG region_NN ;_: DH_NNP =_SYM heavy_JJ chain_NN diversity_NN segment_NN ;_: FR_NNP
        =_SYM framework_NN region_NN ;_: GC_NNP =_SYM germinal_NN centers_NNS ;_: gl_NN =_SYM germline_NN ;_:
        JH_NNP =_SYM heavy_JJ chain_NN joining_VBG segment_NN ;_: PCR_NNP =_SYM polymerase_NN chain_NN
        reaction_NN ;_: RA_NNP =_SYM rheumatoid_NN arthritis_NN ;_: ReA_NNP =_SYM reactive_JJ
        arthritis_NN ;_: SM_NNP =_SYM synovial_NN membrane_NN ;_: VH_NNP =_SYM heavy_JJ chain_NN
        variable_JJ segment_NN ._.
      
    
  
